Precision BioSciences Inc. (NASDAQ: DTIL) announced the U.S. Food and Drug Administration granted Fast Track designation to PBGENE-DMD for treating ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE